Skip to content

No open cycle

This cause does not have an open cycle right now. Your grant status is still available in the dashboard.

Open dashboard
Ban synthetic food dyes
Ban synthetic food dyes
Lobbying

FDA action and scientific re-evaluation

Support FDA’s additive reviews, petitions, and rulemakings to revoke or restrict high-risk dyes and accelerate approval of safer natural alternatives.

Help FDA turn the current attention on synthetic dyes into durable, enforceable national standards. This strategy supports additive reviews, petitions, and rulemakings that revoke or restrict high-risk dyes and clarify what manufacturers must do next. The goal is a predictable federal baseline that reduces the need for a patchwork of state and school rules.

Why this works

  • National impact; creates a single standard that manufacturers can build around.

Public Citizen

Advocacy
citizen.org

Championing consumer rights and accountable government

Public Citizen is a nonprofit consumer advocacy organization founded in 1971 by Ralph Nader. It works to ensure that all citizens are represented in the halls of power by promoting public health and safety, government transparency, and corporate accountability. Public Citizen fights for campaign finance reform and ethics (it helped create the Office of Congressional Ethics:), advocates for safe pharmaceuticals and medical devices, pushes for strong consumer protections in trade deals, and litigates to enforce health, safety, and environmental laws.

Mechanism

About Lobbying

How Public Citizen uses funding

  1. Identify the highest-impact FDA actions already in motion and the decision points that control timelines.
  2. Submit and support petitions, comments, and evidence that strengthen the administrative record for revocations or restrictions.
  3. Brief policymakers and agency leadership to keep prioritization and resourcing aligned with public health goals.
  4. Coordinate with public health advocates to sustain pressure and respond to industry arguments.
  5. Push for clear, usable standards and guidance so compliance is predictable for manufacturers.
  6. Track progress and communicate milestones so momentum is sustained through final decisions.
View full partner profile

Milestones

Checkpoints and the expected timing for each step

  1. 1

    FDA docket and evidence package assembled

    Early

    Priority actions, supporting evidence, and stakeholder narratives are organized for effective participation.

  2. 2

    Comments and petitions strengthened

    During review and rulemaking

    The record includes clear support for revocations, restrictions, and a national standard.

  3. 3

    Draft standard and guidance clarified

    As FDA acts

    Stakeholders can point to clear expectations and a coherent pathway for compliance.

  4. 4

    Final federal actions issued

    At decision point

    A final revocation, restriction, or national standard is published and enforceable.

  5. 5

    Implementation tracked

    After issuance

    Progress is monitored and barriers (like supply constraints) are documented for follow-on fixes.

Risks, trade-offs & sources

Updates

No updates yet.

Updates will appear here as the strategy progresses.

0votes left
Using bonus
0